EN
HI
Glaxosmithkline Pharmaceuticals Chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
1.30 L
Market Cap
38675.40 CR
LTQ@LTP
1@2283.00
ATP
2258.03
Var Margin
16.51 %
Circuit Range
1807.6-2711.4
Delivery %
58.87 %
Value
29.26 CR
ASM/GSM
No
Market Lot
1
Summary
At 30 Mar, 2026 | 15:43, Glaxosmithkline Pharmaceuticals share price stands at ₹2283, showing a 0.00% 0.00 for the day. The stock’s intraday movement has stayed between ₹2217.60 and ₹2296.90, while on a 52-week basis it has fluctuated from ₹2217.60 to ₹3515.70.
In terms of trading activity, Glaxosmithkline Pharmaceuticals has recorded a volume of 129602 shares, with a market capitalisation of ₹169406034. The stock’s Average Traded Price (ATP) stands at ₹225803, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,228300. The stock operates within a circuit range of ₹1807.6-2711.4, with a Value of ₹29.26 CR. The Delivery Percentage for the day is 58.87%. Additionally, Glaxosmithkline Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Glaxosmithkline Pharmaceuticals Fundamentals
View MoreP/E Ratio
38.52
P/B Ratio
19.63
Div. Yield
2.33
Sector P/E
60.12
Sector P/B
3.18
Sec. Div. Yield
0.59
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2265.83
Resistance
First Resistance
2314.06
Second Resistance
2345.13
Third Resistance
2393.36
Support
First Support
2234.76
Second Support
2186.53
Third Support
2155.46
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
Glaxosmithkline Pharmaceuticals News
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals received a demand liability of ₹23.21 crore from ACIT Cir 7(1)(1) for AY 2023-24. The company is contesting this assessment order and is initiating an appeal, with no immediate financial impact.
Mar 24 2026 12:03:00
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30
GlaxoSmithKline Pharmaceuticals received a demand liability of ₹23.21 crore from ACIT for AY 2023-24. The company is contesting the order and stated that there is no immediate financial impact.
Mar 24 2026 12:03:00
Read More
About Glaxosmithkline Pharmaceuticals
NSE : 1153
BSE : 500660
ISIN : INE159A01016
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ms. R S Karnad | Chairperson |
| Mr. B Akshikar | Managing Director |
Glaxosmithkline Pharmaceuticals Similar Stocks
Biocon Ltd.
360.90
0.00 (0.00%)
Abbott India Ltd.
25915.00
0.00 (0.00%)
Laurus Labs Ltd.
992.70
0.00 (0.00%)
Ipca Laboratories Ltd.
1601.20
0.00 (0.00%)
Anthem Biosciences Ltd.
656.25
0.00 (0.00%)
Ajanta Pharma Ltd.
2805.10
0.00 (0.00%)
Aster DM Healthcare Ltd.
670.00
0.00 (0.00%)
Narayana Hrudayalaya Ltd.
1605.30
0.00 (0.00%)
JB Chemicals & Pharmaceuticals Ltd.
2064.40
0.00 (0.00%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2283 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 38.52. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 19.63. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 60.12 & 3.18 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 38675.40 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 3515.70 & 2217.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
